Preferred Name |
Linagliptin [Chemical/Ingredient] |
|
Synonyms |
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- |
|
ID |
http://purl.bioontology.org/ontology/NDFRT/N0000191976 |
|
altLabel |
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Linagliptin |
|
cui |
C2746078 |
|
MESH DEFINITION |
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. |
|
MESH DUI |
D000069476 |
|
MeSH name |
Linagliptin |
|
MESH UI |
M0554626 |
|
NDFRT kind |
INGREDIENT_KIND |
|
notation |
N0000191976 |
|
NUI |
N0000191976 |
|
prefLabel |
Linagliptin [Chemical/Ingredient] |
|
tui |
T109 T121 |
|
subClassOf |